№ files_lp_4_process_3_138115
Press release presenting clinical trial findings and conference presentations reporting two-year results from the multinational PROTECT randomized study evaluating NaturalVue® Multifocal contact lenses and their relationship to myopia progression and associated risk factors in pediatric populations.
Year: 2026
Date: January 8, 2026
Location: Las Vegas, Nevada, United States
Document Type: Press Release
Organization: Visioneering Technologies, Inc.
Subject: Myopia management and multifocal contact lenses
Product: NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lens
Clinical Trial: PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial)
Study Duration: 3 years
Reported Data Period: 2-year results
Study Population: Children aged 8–12
Sample Size: 145 participants
Participating Regions: United States, Canada, Hong Kong, Singapore
Key Researchers Mentioned: Ashley Tuan, OD, PhD, FAAO; Brett O’Connor, OD, FAAO
Event: Global Specialty Lens Symposium (GSLS)
Additional Presentation: American Academy of Optometry, October 10, 2025, Boston, MA
Research Topic: Clinical, familial, and social risk factors affecting myopia progression
Power Range Studied: −0.75 to −4.00 diopters
Astigmatism Data Source: Universidad Complutense de Madrid, Spain
Regulatory Note: Some described uses not approved by the FDA in the United States
Contact: Layna L. Mendlinger
Contact Email: [email protected]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.